ROLAND MCKENDREE: Open Payments
NPI 1841639945 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 54 payments from 15 companies in 2025. Trend: 2023 $1,211 · 2024 $880 · 2025 $981
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $179 |
| Novo Nordisk Inc | 11 | $178 |
| Lilly USA, LLC | 6 | $131 |
| PFIZER INC. | 4 | $79 |
| Sumitomo Pharma America, Inc. | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Boston Scientific Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
Products named: OTEZLA, Wegovy, Ozempic, GEMTESA, JARDIANCE, TRELEGY ELLIPTA, LEQVIO, MOUNJARO.
Industry payments across FL — which companies pay providers there.
